STAT
MARCH 20, 2025
NEW YORK — A former top federal health official is publicly warning Robert F. Kennedy Jr. that wavering on vaccines and slashing federal programs during a deadly measles outbreak could unleash the next public health disaster. “The federal government might pause, but the measles virus doesn’t pause. Bacteria and viruses don’t pause.
Express Pharma
MARCH 20, 2025
Eli Lilly and Company (India) announced the launch of Mounjaro in single-dose vial presentation following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 20, 2025
Wholesale egg prices have dropped by more than 40% since late February, a decline that should soon translate into broader savings for consumers at grocery stores. This welcome respite has largely resulted from the lull in significant bird flu outbreaks in recent weeks, perhaps due to seasonal patterns in the virus’s transmission. North American flyways typically remain quiet in February as migratory birds have yet to start their journeys from their winter habitats.
Pharma Marketing Network
MARCH 20, 2025
Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
MARCH 20, 2025
TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management device maker Zynex Medical. In a recent filing with the Securities and Exchange Commission, Zynex revealed that the government payer — which represents up to a quarter of Zynex’s annual revenue — was suspending payments as it reviewed prior claims.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
MARCH 20, 2025
NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship; approved therapies aren’t being prescribed. Yet both he and University of Pennsylvania researcher Kiran Musunuru are forging ahead, using contrasting approaches, as they explained onstage at STAT’s Breakthrough Summit East.
Pharma Marketing Network
MARCH 20, 2025
Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. Ad retargeting has become a powerful tool for pharma marketers, enabling brands to re-engage potential customers who have shown interest but have not yet converted. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?
STAT
MARCH 20, 2025
Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.
The Pharmacist
MARCH 20, 2025
Pharmacy leaders have expressed hope that the long awaited pharmacy contract will include an uplift to cover increased National Insurance Contributions (NICs), after MPs voted yesterday against exempting pharmacy employers from the measure. Last month, peers in the House of Lords voted to freeze NICs for primary care employersat 13.8%. This would have seen them […] The post Hopes pharmacy contract will include NI uplift after 'disappointing' MPs vote appeared first on The Pharmac
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
MARCH 20, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! There’s sure to be a lot of news coming out of the Breakthrough Summit East today, which is taking place just a few blocks away from my favorite Shake Shack in Manhattan. In-person tickets are sold out, but you can still snag a virtual ticket here.
Drug Patent Watch
MARCH 20, 2025
Navigating the Complex World of Biosimilar Regulatory Agency Interactions As a biosimilar developer, you know that getting your product to market can be a long and arduous process. One of the most critical components of this journey is interacting with regulatory agencies. But how can you ensure that these interactions are effective and set your product up for success?
STAT
MARCH 20, 2025
NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of the company — said he was confident in the company’s obesity plans and shed light on why he joined the pharmaceutical giant. Andrew Baum was managing director of equity research at Citigroup until last May, when Pfizer announced that he would take on the role of chief strategy and innovation officer.
PharmaVoice
MARCH 20, 2025
The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also enduring tragic risk.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
MARCH 20, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. A panel of experts at a leading speciality society announced in a new clinical guideline that they have decided not to decide whether to recommend AI-assisted colonoscopies.
The Pharmacist
MARCH 20, 2025
The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of suicidality as previously suggested, an analysis of UK data has found. A study comparing GP records of patients taking GLP-1RA drugs and those taking dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT2) inhibitors found […] The post Semaglutide not associated with increased risk of suicide, say researchers appeared first on The Pharmacist
STAT
MARCH 20, 2025
The GLP-1 class of drugs used to treat diabetes and obesity may have the potential to benefit huge swaths of the public, but ongoing employer concerns over cost and a lack of patient adherence remain stubborn obstacles to wider adoption, a pair of health executives explained Thursday. The medicines have proven wildly popular and, in turn, have generated huge sales, long stretches of shortages, and unchecked excitement among investors.
Drug Patent Watch
MARCH 20, 2025
Unlock the Full Potential of Your Pharmaceutical Product: The Power of a CDMO As a pharmaceutical professional, you're constantly looking for ways to bring innovative products to market faster and more efficiently. One key strategy that can help you achieve this goal is partnering with a Contract Development and Manufacturing Organization (CDMO). But what exactly is a CDMO, and how can it benefit your business?
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
STAT
MARCH 20, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Happy “Severance” finale day to all who celebrate.
BioPharma Dive
MARCH 20, 2025
Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a competitive and fast-changing market.
Pharmaceutical Business Review
MARCH 20, 2025
This collaboration leverages Porton Advanced’s cell and gene therapy manufacturing offerings and Artemiscell receptor as well as the EALPHAantibody discovery platforms of Eureka. Through this partnership, Porton Advanced will provide CAR-T manufacturing services for investigator-initiated trials (IITs) of Eureka, ensuring compliance with quality standards.
The Pharmacist
MARCH 20, 2025
The final version of the economic analysis of community pharmacy report has been shared with Community Pharmacy England (CPE) and other stakeholders, it has been confirmed. But the highly anticipated report will not be published before the pharmacy contract talks finish, NHS England (NHSE) has stressed. NHSEs national director for primary care and community service, […] The post 'Final version' of pharmacy economic review shared with CPE appeared first on The Pharmacist.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Script
MARCH 20, 2025
Are you butting heads with your colleagues? Our team at Rx relief describes three conflict resolution tactics you should implement.
Pharmaceutical Technology
MARCH 20, 2025
OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.
pharmaphorum
MARCH 20, 2025
A study has suggested early targeting of amyloid in the brains of people with inherited Alzheimer's can delay symptoms, but not all are convinced.
BioPharma Dive
MARCH 20, 2025
To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as Zolgensma, could be approved for a broad range of spinal muscular atrophy patients.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Expert insights. Personalized for you.
350 
Let's personalize your content